Safety and Effectiveness of Balloon-Expandable Bioprosthetic SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
Edwards Lifesciences
Summary
The objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4 Transcatheter Heart Valve (THV) in subjects who are at high or greater risk with a failing aortic bioprosthetic valve.
Description
Prospective, single arm, multicenter study
Eligibility
- Age range
- Not specified
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: 1. Failing aortic bioprosthetic valve demonstrating ≥ moderate stenosis and/or ≥ moderate insufficiency 2. Bioprosthetic valve size suitable for SAPIEN X4 THV 3. NYHA functional class ≥ II 4. Heart Team agrees the subject is at high or greater surgical risk 5. The subject has been informed of the nature of the study, agrees to its provisions and has provided written informed consent. Exclusion Criteria: 1. Anatomical characteristics that would preclude safe femoral placement of the introducer sheath or safe passage of the delivery system 2. Failing valve has moderate or…
Interventions
- DeviceSAPIEN X4 THV
Implantation of the SAPIEN X4 valve
Locations (35)
- Hoag Memorial Hospital PresbyterianNewport Beach, California
- Bay Area Structural Heart at Sutter HealthSan Francisco, California
- Kaiser San FranciscoSan Francisco, California
- Stanford University Medical CenterStanford, California
- UC Health Medical Center of the RockiesLoveland, Colorado
- Naples Community Hospital Healthcare SystemNaples, Florida